![](/img/cover-not-exists.png)
An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC
Yonesaka, Kimio, Takegawa, Naoki, Watanabe, Satomi, Haratani, Koji, Kawakami, Hisato, Sakai, Kazuko, Chiba, Yasutaka, Maeda, Naoyuki, Kagari, Takashi, Hirotani, Kenji, Nishio, Kazuto, Nakagawa, KazuhiLanguage:
english
Journal:
Oncogene
DOI:
10.1038/s41388-018-0517-4
Date:
October, 2018
File:
PDF, 2.47 MB
english, 2018